Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlus500 Regulatory News (PLUS)

Share Price Information for Plus500 (PLUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,266.00
Bid: 2,258.00
Ask: 2,268.00
Change: -4.00 (-0.18%)
Spread: 10.00 (0.443%)
Open: 2,240.00
High: 2,274.00
Low: 2,240.00
Prev. Close: 2,270.00
PLUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ESMA Update

18 Dec 2017 07:00

RNS Number : 5756Z
Plus500 Limited
18 December 2017
 

18 December 2017

Plus500 Ltd.

("Plus500" or "the Company")

ESMA Update

Plus500, a leading online service provider for retail customers to trade CFDs internationally, today provides an update regarding the recent statement by ESMA, the European Securities and Markets Authority.

 

ESMA provided an updated statement on the preparatory work in relation to CFDs and other products offered to retail clients on Friday 15 December. It also commented that it will conclude its consultation in January 2018 with official trading restrictions to be announced then.

 

Plus500 welcomes this statement and the strong regulatory framework that this will bring to the industry. On the main points highlighted by this statement, Plus500 reiterates that the Company has never offered binary options and has always provided balance protection to its customers across all its product offerings in all its markets, as a core principle of its business model. The Company also has a maintenance margin level which enables its customers to have additional protection. As at January 2017, Plus500 removed its bonus schemes for the vast majority of its operations.

At this stage, Plus500 will wait for the conclusion of the consultation expected in January 2018 to understand where it will need to implement necessary adjustments to its business model.

 

Asaf Elimelech, CEO of Plus500 commented: "It is positive to have an update from ESMA, as this provides us with more transparency as to the regulatory changes that may be implemented in January 2018.

 

We look forward to working with our regulators through the consultation period and establishing detailed procedures to ensure the proposed measures operate effectively. Until those details are finalised, it is difficult to assess the impact upon our business, however, as we have previously stated, we have a flexible business model, already provide many of the protections suggested by ESMA, and are well diversified globally, now with seven licenses in different jurisdictions following the recent licence approval in Singapore earlier this month."

 

 

For further information please contact:

 

Plus500 Ltd +972 4 8189503

Elad Even-Chen, Chief Financial Officer

 

Liberum - Nomad and Broker +44 20 3100 2222

Clayton Bush, Neil Elliot, Josh Hughes

 

Berenberg (Joint Broker) +44 20 3207 7800

Chris Bowman, Mark Whitmore

 

MHP Communications +44 20 3128 8100

Reg Hoare, Tim Rowntree, Kelsey Traynor

 

 

About Plus500

 

Plus500 operates an online trading platform for retail customers to trade CFDs internationally over more than 2,200 different underlying global financial instruments comprising equities, indices, commodities, options, ETFs, crypto currencies and foreign exchange. Retail customers of Plus500 can trade CFDs in more than 50 countries and in 32 languages. The trading platform is also accessible from multiple operating systems (Windows, smartphones (iOS, Android and Windows Phone), tablets (iOS, Android and Surface), Apple Watch and web browsers).

Plus500 retains operating licences and is regulated in the United Kingdom, Australia, Cyprus, New Zealand, Israel, South Africa and Singapore. Customer care is integral to Plus500: customers cannot be subject to negative balances, there are no commissions on trades. Plus500 does not utilise cold calling techniques and does not offer binary options. A free demo account is available on an unlimited basis for platform users and sophisticated risk management tools are provided free of charge to manage leverage and stop losses to help customers protect profits and limit capital losses

www.plus500.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKODQOBDDNBD
Date   Source Headline
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20243:41 pmRNSStandard form for notification of major holdings
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20241:18 pmRNSEGM Results
8th Jan 20247:00 amRNSYear End Trading Update
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSDirector/PDMR Dealing and Total Voting Rights
3rd Jan 20247:00 amRNSGrant of RSUs and Ordinary shares awards
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSPassing away of Non-Executive Director
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSNotice of Extraordinary General Meeting
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20233:44 pmRNSHolding(s) in Company
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.